Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-arterial Melphalan for Retinoblastoma
NCT00906113Phase 2Unknown
- Sponsor
- Hadassah Medical Organization
- Start
- Jun 2011
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of melphalan in retinoblastoma (Rb), sponsored by Hadassah Medical Organization. Status: unknown.
02
Drugs
melphalan
03
Conditions
retinoblastoma (Rb)
Beyond the preview
Go deeper on NCT00906113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00906113.